World's Best Scientists 2026 revealed!
Yazdan Yazdanpanah

Yazdan Yazdanpanah

D-Index & Metrics

Medicine

D-Index
80
Citations
26581
World Ranking
17010
National Ranking
558

Overview

Yazdan Yazdanpanah is affiliated with Université Paris Cité in France and has a significant body of work primarily in the field of medicine, with a focus on infectious diseases. Their research spans across epidemiology, virology, general health professions, and molecular biology.

Their main fields of study include:

  • Medicine

Within the subfields, Yazdanpanah's work covers:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • General Health Professions
  • Molecular Biology

The scientist's research topics are diverse, with a strong emphasis on viral infections and public health concerns. These topics include:

  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing
  • Poxvirus research and outbreaks

Yazdanpanah has published extensively in various scientific journals and venues, frequently contributing to:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Microbiology and Infection
  • Médecine et Maladies Infectieuses
  • Médecine et Maladies Infectieuses Formation
  • Infectious Diseases Now

Among their recent papers are:

  • "Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients" (2020) published in Emerging Infectious Diseases
  • "Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study" (2020) published in The Lancet
  • "Clinical and virological data of the first cases of COVID-19 in Europe: a case series" (2020) published in The Lancet Infectious Diseases
  • "Type 1 interferons as a potential treatment against COVID-19" (2020) published in Antiviral Research
  • "Monkeypox" (2022) published in New England Journal of Medicine

Yazdanpanah collaborates frequently with other researchers, including:

  • François-Xavier Lescure
  • Nathan Peiffer-Smadja
  • Diane Descamps
  • France Mentré
  • Jade Ghosn

Best Publications

  • Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients

    Nisreen M.A. Okba;Marcel A. Müller;Wentao Li;Chunyan Wang

  • Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study

    Marius Gilbert;Giulia Pullano;Francesco Pinotti;Eugenio Valdano

  • Clinical and virological data of the first cases of COVID-19 in Europe: a case series.

    Francois-Xavier Lescure;Francois-Xavier Lescure;Lila Bouadma;Lila Bouadma;Duc Nguyen;Marion Parisey

  • European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

    Jean-François Rahier;F Magro;C Abreu;A Armuzzi

  • Evidence of Sexual Transmission of Zika Virus

    Eric D'Ortenzio;Sophie Matheron;Yazdan Yazdanpanah;Xavier de Lamballerie

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.

    Daouda Sissoko;Cedric Laouenan;Elin Folkesson;Abdoul-Bing M’Lebing

  • Type 1 interferons as a potential treatment against COVID-19.

    Erwan Sallard;François Xavier Lescure;Yazdan Yazdanpanah

  • Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

    David A. Margolis;Juan Gonzalez-Garcia;Hans Jürgen Stellbrink;Joseph J. Eron

  • Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.

    Alfredo Alberti;Nathan Clumeck;Simon Collins;Wolfram Gerlich

  • Severe SARS-CoV-2 infections: practical considerations and management strategy for intensivists.

    Lila Bouadma;Francois Xavier Lescure;Jean Christophe Lucet;Yazdan Yazdanpanah

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

    Florence Ader;Maude Bouscambert-Duchamp;Maya Hites;Nathan Peiffer-Smadja;Nathan Peiffer-Smadja

  • High rate of virologic suppression with raltegravir plus etravirine and darunavir/ritonavir among treatment-experienced patients infected with multidrug-resistant HIV: results of the ANRS 139 TRIO Trial.

    Y. Yazdanpanah;C. Fagard;D. Descamps;A. M. Taburet

  • Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.

    Jürgen K Rockstroh;Edwin DeJesus;Jeffrey L Lennox;Yazdan Yazdanpanah

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis

    Nathalie Viget;Gwenola Vernier-Massouille;Dominique Salmon-Céron;Yazdan Yazdanpanah

  • Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia

    Andrés Pizzorno;Blandine Padey;Thomas Julien;Sophie Trouillet-Assant;Sophie Trouillet-Assant

  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

    Ludivine Grzelak;Ludivine Grzelak;Sarah Temmam;Cyril Planchais;Caroline Demeret

  • WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus

    Holger J Schünemann;Suzanne R Hill;Meetali Kakad;Richard Bellamy

  • Review of human immunodeficiency virus type 1-related opportunisticinfections in sub-Saharan Africa

    C. B. Holmes;E. Losina;R. P. Walensky;Y. Yazdanpanah

Frequent Co-Authors

Jean-François Timsit
Jean-François Timsit Université Paris Cité
Bruno Lina
Bruno Lina Claude Bernard University Lyon 1
Stanislas Pol
Stanislas Pol Université Paris Cité
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University
Patrice Cacoub
Patrice Cacoub Sorbonne University
Jacques Reynes
Jacques Reynes University of Montpellier
Fabrice Carrat
Fabrice Carrat Sorbonne University
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Dominique Larrey
Dominique Larrey University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up a variety of educational journeys beyond the traditional MD route. Many students are now exploring flexible online degrees that cater to different interests, schedules, and long-term goals.

For those interested in advanced nursing, dnp programs without dissertation offer a way to earn a terminal degree in nursing without the pressure of completing a traditional dissertation, making it more accessible for working professionals.

If you’re looking to enter the workforce quickly, the 9 month lpn program provides a fast-track pathway to become a Licensed Practical Nurse in less than a year, all through online courses.

Mental health practitioners can take advantage of online msn pmhnp programs, which prepare nurses for specialization in psychiatric and mental health without lengthy campus commitments.

For those drawn to leadership and policy, healthcare administration degrees online deliver the skills needed to manage complex healthcare systems at an affordable cost.

Exploring these alternative online options can help you find a career path in healthcare that suits your lifestyle and professional goals.

Best Scientists Citing Yazdan Yazdanpanah

Trending Scientists

Recently Published Articles